Details of the Drug

General Information of Drug (ID: DM1ZHML)

Drug Name
HPN328
Indication
Disease Entry ICD 11 Status REF
Small-cell lung cancer 2C25.Y Phase 1/2 [1]
Cross-matching ID
TTD ID
DM14CQ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Delta-like protein 3 (DLL3) TT1C9K6 DLL3_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04471727) Study in Patients With Advanced Cancers Associated With Expression of DLL3 Who Have Failed Standard Available Therapy. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Harpoon Therapeutics.